U + life the era of microchip medicine
Regius Professor Chris Toumazou presents the 2015 Gabor lecture.
Many countries are facing an ageing population and a rise in the chronic diseases associated with it such as diabetes, obesity, cardiovascular disease and kidney disease. Societies need to manage these better otherwise the financial costs will continue to escalate to unsustainable levels.
To address these challenges, Regius Professor Toumazou has developed an innovative healthcare concept and brand called U+ Life. This harnesses the power of semiconductor technology and microchips for the treatment of chronic diseases. It provides personalised solutions for early detection, point of care diagnostics and therapeutics to help tackle the global problem of chronic disease in a consumer-oriented way. The U+ Life brand bridges lifestyle and epigenetics with applications ranging from the beauty industry to oncology.
To find out more please visit